Previous Close | 58.37 |
Open | 58.75 |
Bid | 60.26 x 1200 |
Ask | 60.91 x 800 |
Day's Range | 57.30 - 58.75 |
52 Week Range | 50.27 - 76.04 |
Volume | |
Avg. Volume | 1,686,976 |
Market Cap | 12.874B |
Beta (5Y Monthly) | 0.65 |
PE Ratio (TTM) | 21.64 |
EPS (TTM) | 2.65 |
Earnings Date | Apr 30, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 75.41 |
Subscribe to Yahoo Finance Plus to view Fair Value for INCY
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Incyte's (INCY) Opzelura leads to a significantly greater reduction in abscess and inflammatory nodule (AN) count in HS patients.